A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282
- 18 April 2005
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 62 (5) , 1345-1350
- https://doi.org/10.1016/j.ijrobp.2004.12.074
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Pancreatic cancerCurrent Treatment Options in Oncology, 2000
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canalCancer, 1983
- Combined modality therapy for esophageal squamous cell carcinomaCancer, 1983
- Reporting results of cancer treatmentCancer, 1981
- Infusional 5-fluorouracil and x-ray therapy for non-resectable esophageal cancerCancer, 1980
- 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer. A Southwest oncology group studyCancer, 1979
- Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreasCancer, 1973
- Treatment of Malignant Neoplasms of the Gastrointestinal Tract With a Combination of 5-Fluorouracil and RadiationRadiology, 1965